Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV accessory proteins and surviving the host cell.

Jenny L Anderson1, Thomas J Hope

  • 1Department of Microbiology and Immunology, The University of Illinois at Chicago, Chicago, IL 60612, USA. thope@uic.edu

Current HIV/AIDS Reports
|August 11, 2005
PubMed
Summary

Human immunodeficiency virus accessory proteins like Vif are crucial for disease progression in the body. Targeting these viral proteins offers a promising strategy for developing new HIV therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Spatial Biology of HIV Transmission and Infection: Imaging the Female and Male Reproductive Tracts.

American journal of reproductive immunology (New York, N.Y. : 1989)·2026
Same author

A Tissue Virus Microenvironment with Activated Stress Responses Underlies Durable SIV Persistence.

bioRxiv : the preprint server for biology·2026
Same author

Pathological phimosis is associated with foreskin immune cell infiltration but not microbiota composition.

mSphere·2026
Same author

The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir.

PLoS pathogens·2026
Same author

<i>S</i>‑Adenosylhomocysteine Analogs Selectively Suppress Pan-Coronavirus Replication by Inhibition of nsp14 Methyltransferase.

ACS medicinal chemistry letters·2026
Same author

Ethically Integrating Genomics in Primary Care: An Invitation to Share Implementation Best Practices.

Mayo Clinic proceedings·2025

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Human immunodeficiency virus (HIV) produces accessory proteins including Nef, viral infectivity factor (Vif), viral protein R, and viral protein U/X.
  • These accessory proteins, though often inactive in laboratory settings, are vital for HIV's ability to cause disease within a host.
  • Understanding how these proteins function is key to developing effective antiviral treatments.

Purpose of the Study:

  • To review recent insights into the function of HIV accessory proteins, particularly Vif.
  • To emphasize the interactions between these viral proteins and host cells.
  • To identify new therapeutic targets for HIV intervention.

Main Methods:

  • Review of recent scientific literature on HIV accessory proteins.

Related Experiment Videos

  • Analysis of data on Vif's role in perturbing host antiviral pathways.
  • Focus on host-pathogen interactions.

    • Main Results:

    • HIV accessory proteins manipulate host cells to facilitate viral pathogenesis.
    • The viral infectivity factor (Vif) specifically disrupts host antiviral mechanisms, enabling HIV replication.
    • Accessory proteins are essential for in vivo viral pathogenesis.

    Conclusions:

    • HIV accessory proteins represent critical targets for antiviral drug development.
    • Further research into Vif and other accessory proteins' interactions with host cells can reveal novel therapeutic strategies.
    • Targeting host cell manipulation by HIV proteins is a promising avenue for HIV treatment.